Trademark: 88768088
Word
NOURIN
Status
Registered
Status Code
700
Status Date
Tuesday, February 16, 2021
Serial Number
88768088
Registration Number
6274061
Registration Date
Tuesday, February 16, 2021
Mark Type
4000
Filing Date
Tuesday, January 21, 2020
Published for Opposition
Tuesday, June 9, 2020

Trademark Owner History
Nour Heart, Inc. - Original Registrant

Classifications
1 protein arrays for research purposes; gene-based RNA molecular network being RNA sequences for research purposes; protein arrays for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for research purposes; gene-based RNA molecular network being RNA sequences for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for research use; diagnostic biomarker reagents for research purposes; protein arrays of biomarker reagents for research purposes; gene-based RNA molecular network biomarker reagents for research purposes; protein arrays and gene-based RNA molecular network biomarker reagents for research purposes; tissue-derived diagnostic biomarker reagents for research purposes; cardiac-derived diagnostic biomarker reagents for research purposes
5 protein arrays for medical diagnosis purposes; gene-based RNA molecular network being RNA sequences for medical diagnosis purposes; protein arrays for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for medical diagnosis purposes; gene-based RNA molecular network being RNA sequences for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for medical use; diagnostic biomarker reagents for medical purposes; protein arrays of biomarker reagents for medical diagnosis purposes; gene-based RNA molecular network biomarker reagents for medical diagnosis purposes; protein arrays and gene-based RNA molecular network biomarker reagents for medical diagnosis purposes; tissue-derived diagnostic biomarker reagents for medical purposes; cardiac-derived diagnostic biomarker reagents for medical purposes

Trademark Events
Feb 16, 2021
Registered-Principal Register
Jan 15, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 14, 2021
Allowed Principal Register - Sou Accepted
Jan 14, 2021
Statement Of Use Processing Complete
Dec 22, 2020
Use Amendment Filed
Jan 13, 2021
Case Assigned To Intent To Use Paralegal
Dec 22, 2020
Teas Statement Of Use Received
Aug 4, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 9, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2020
Published For Opposition
May 20, 2020
Notification Of Notice Of Publication E-Mailed
May 5, 2020
Approved For Pub - Principal Register
Apr 25, 2020
Teas/Email Correspondence Entered
Apr 24, 2020
Correspondence Received In Law Office
Apr 24, 2020
Teas Response To Office Action Received
Apr 13, 2020
Notification Of Non-Final Action E-Mailed
Apr 13, 2020
Non-Final Action E-Mailed
Apr 13, 2020
Non-Final Action Written
Apr 8, 2020
Assigned To Examiner
Jan 25, 2020
New Application Office Supplied Data Entered In Tram
Jan 24, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24